🚀 VC round data is live in beta, check it out!

Omada Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Omada Health and similar public comparables like Bayzed Health Group, Certara, Nutex Health, Yidu Tech and more.

Omada Health Overview

About Omada Health

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor’s visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.


Founded

2011

HQ

United States

Employees

849

Financials (LTM)

Revenue: $280M
EBITDA: $8M

EV

$714M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Omada Health Financials

Omada Health reported last 12-month revenue of $280M and EBITDA of $8M.

In the same LTM period, Omada Health generated $197M in gross profit, $8M in EBITDA, and had net loss of ($10M).

Revenue (LTM)


Omada Health P&L

In the most recent fiscal year, Omada Health reported revenue of $260M and EBITDA of $6M.

Omada Health is unprofitable as of last fiscal year, with gross margin of 66%, EBITDA margin of 2%, and net margin of (5%).

See analyst estimates for Omada Health
LTMLast FY202320242025202620272028
Revenue$280M$260M$123M$170M$260M
Gross Profit$197M$171M$70M$103M$171M
Gross Margin70%66%57%61%66%
EBITDA$8M$6M($58M)($38M)($5M)
EBITDA Margin3%2%(48%)(22%)(2%)
EBIT Margin2%2%(54%)(26%)(5%)
Net Profit($10M)($13M)($68M)($47M)($13M)
Net Margin(4%)(5%)(55%)(28%)(5%)

Financial data powered by Morningstar, Inc.

Omada Health Stock Performance

Omada Health has current market cap of $907M, and enterprise value of $714M.

Market Cap Evolution


Omada Health's stock price is $15.27.

Omada Health share price increased by 4.7% in the last 30 days.

Omada Health has an EPS (earnings per share) of $-0.22.

See more trading valuation data for Omada Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$714M$907M4.7%4.7%24.3%—$-0.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Omada Health Valuation Multiples

Omada Health trades at 2.6x EV/Revenue multiple, and 88.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Omada Health

EV / Revenue (LTM)


Omada Health Financial Valuation Multiples

As of May 2, 2026, Omada Health has market cap of $907M and EV of $714M.

Omada Health has a P/E ratio of (87.6x).

LTMLast FY202320242025202620272028
EV/Revenue2.6x2.7x5.8x4.2x2.7x
EV/EBITDA88.4x110.2x(12.2x)(18.9x)(150.2x)
EV/EBIT113.6x110.4x(10.8x)(16.4x)(59.6x)
EV/Gross Profit3.6x4.2x10.2x6.9x4.2x
P/E(87.6x)(71.0x)(13.4x)(19.2x)(71.0x)
EV/FCF49.7x54.3x(13.6x)(18.8x)57.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Omada Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Omada Health Margins & Growth Rates

Omada Health grew revenue by 23% and EBITDA by 74% in the last fiscal year.

In the most recent fiscal year, Omada Health reported gross margin of 66%, EBITDA margin of 2%, and net margin of (5%).

See estimated margins and future growth rates for Omada Health

Omada Health Margins

Last FY202420252026202720282029
Gross Margin66%61%66%71%
EBITDA Margin2%(22%)(2%)4%
EBIT Margin2%(26%)(5%)2%
Net Margin(5%)(28%)(5%)(2%)
FCF Margin5%(22%)5%5%

Omada Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth23%38%53%23%
Gross Profit Growth33%47%66%33%
EBITDA Growth74%(35%)(87%)(337%)
EBIT Growth(9%)(34%)(73%)(149%)
Net Profit Growth(57%)(30%)(73%)(57%)
FCF Growth28%(28%)(133%)35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Omada Health Operational KPIs

Omada Health's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Omada Health's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Omada Health's Rule of X is 60% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Omada Health
LTMLast FY202320242025202620272028
Rule of 4024%26%———
Bessemer Rule of X57%60%———
Revenue per Employee—$0.3M———
Opex per Employee—$0.2M———
S&M Expenses to Revenue34%35%54%40%35%
G&A Expenses to Revenue18%20%29%25%20%
R&D Expenses to Revenue15%16%27%21%16%
Opex to Revenue—70%111%86%70%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Omada Health Competitors

Omada Health competitors include Bayzed Health Group, Certara, Nutex Health, Yidu Tech, Enhabit, CareDx, InnovAge, Summerset Group Holdings, Ambea and Indegene.

Most Omada Health public comparables operate across Health Data & Analytics and Long-Term Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Bayzed Health Group5.1x—49.9x—
Certara2.5x2.5x7.9x8.0x
Nutex Health1.3x1.2x3.9x4.1x
Yidu Tech4.7x4.0x(37.6x)(37.5x)
Enhabit1.1x1.1x20.0x10.7x
CareDx2.5x2.3x29.9x24.7x
InnovAge1.3x1.2x31.9x16.6x
Summerset Group Holdings11.0x8.0x13.2x14.4x

This data is available for Pro users. Sign up to see all Omada Health competitors and their valuation data.

Start Free Trial

Omada Health Funding History

Before going public, Omada Health raised $448M in total equity funding, across 7 rounds.

Last private valuation of Omada Health was $1B, after raising $192M in February 2022 from aMoon Fund, Civilization Ventures, Empede Capital, and 5 other investors.


Omada Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Feb-22Series EaMoon Fund; Civilization Ventures; Empede Capital; Fidelity; Perceptive Advisors; Revelation Partners; Trousdale Ventures; Wellington Management$192M$1B—
May-20Undisclosed stagePerceptive Advisors$57M$613MOmada Health is a digital chronic disease management company founded in 2011 that provides virtual and in-person programs for preventing and managing chronic conditions including prediabetes, type 2 diabetes, hypertension, and musculoskeletal conditions. The company combines data-driven one-on-one health coaching, connected devices, and interactive lessons to help patients build healthy behavior patterns. Omada's platform enables users to track diet, exercise, blood glucose, and other health metrics while accessing virtual care support from licensed healthcare professionals. On May 19, 2020, Omada raised $112.47 million in a Series D funding round at a $612.85 million post-money valuation. The round was led by Andreessen Horowitz with participation from multiple investors including Perceptive Advisors, Cigna Ventures, Kaiser Permanente Ventures, Sanofi-Genzyme Bioventures, and others. The company used the capital to accelerate product innovation and expand its presence in the healthcare IT market. In 2020, Omada also acquired Physera, a telehealth company specializing in personalized physical therapy delivery via smartphone. This acquisition allowed Omada to add musculoskeletal care solutions to its portfolio, broadening its service offerings beyond cardiometabolic conditions. The integration of Physera's digital physical therapy capabilities positioned Omada to deliver comprehensive whole-person care across multiple chronic condition categories. By its Series E round in February 2022, Omada had raised a cumulative $444.57 million across multiple funding rounds and was valued at $1 billion. The company continued to expand its clinical capabilities and technology infrastructure. In June 2025, Omada Health went public through an IPO, raising $150.1 million and validating the commercial viability of its digital chronic disease management approach.
Jun-19Series DAllumia Ventures; Andreessen Horowitz; Cigna Ventures; Civilization Ventures; Kaiser Permanente; Norwest; Sanofi Ventures; U.S. Venture Partners; Wellington Management$73M$600MOmada Health, a San Francisco-based digital chronic disease management company founded in 2011, raised $73 million in a Series D funding round on June 26, 2019, led by Wellington Management Company, with participation from Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures, and Allumia Ventures. The round reportedly valued the company at $600 million post-money. This brought Omada's total funding to over $200 million at the time. The capital was primarily directed toward deepening existing customer relationships through expansion into new indications like cardiac or respiratory health and programs addressing risk factors such as smoking, alongside accelerating commercialization with health plans and employers. Omada provides virtual care programs combining health coaching, connected devices, peer support, and digital interventions for chronic conditions including diabetes prevention and self-management, hypertension, and behavioral health following the acquisition of Lantern’s assets earlier in 2019. The company served more than 550 employer clients, over 35 health plans, and partners like Lowe’s, Blue Cross Blue Shield of Minnesota, and Kaiser Permanente, positioning itself as a holistic alternative to competitors like Livongo, Vida Health, and Lark Health. The funding supported Omada's strategy to integrate its solutions into existing healthcare business models and payment schemes, enhancing scalability for payers and employers tackling costly chronic diseases. CEO Sean Duffy emphasized optimizing outcomes, experiences, and cost savings through digital means, with the investor roster underscoring strong industry validation.
Jun-17Series CCigna; Civilization Ventures; Norwest; Sanofi Ventures; U.S. Venture Partners$50M—Omada Health, a San Francisco-based digital health company founded in 2011, provides virtual-first care platforms for managing chronic conditions like prediabetes, Type 2 diabetes, hypertension, and musculoskeletal issues through online coaching, behavioral science, and integration with wearables. In June 2017, it raised $50 million in a Series C1 funding round led by Cigna, with participation from new investors Civilization Ventures and Sanofi Genzyme BioVentures (Sanofi Ventures), as well as returning investors including U.S. Venture Partners, Norwest Venture Partners, Andreessen Horowitz, Providence Ventures, Humana, Kaiser Permanente Ventures, dRx Capital, and GE Ventures. This brought Omada's total funding at the time to over $125 million. The investment validated Omada's clinically proven diabetes prevention program, endorsed by the CDC and Medicare, aimed at reducing healthcare costs through preventive behavioral changes. The round coincided with a strategic partnership where Cigna-administered health plans gained no-cost access to Omada's digital behavioral health programs as a fully covered preventive benefit, though non-exclusive, allowing Omada to work with other payers like Humana and Kaiser Permanente. Cigna highlighted the collaboration as advancing behavior science for habit change and future healthcare delivery. Omada's platform integrates wellness coaches, social networking, activity trackers, and Bluetooth scales, gaining traction with providers like Intermountain Healthcare for its real-world results in chronic disease prevention. Payer investments like Cigna's underscored the push for digital health adoption to address rising chronic disease costs, with Omada competing in a crowded field of platforms leveraging consumer devices for engagement. The partnership expanded over time into full Diabetes Prevention Programs and additional care areas, positioning Omada as a preferred provider in Cigna's Digital Health Formulary by 2021.
Sep-15Series CAndreessen Horowitz; Designer Fund; dRx Capital; GE Power India; Humana Inc.; Norwest; Providence Health & Services; Rock Health Capital; U.S. Venture Partners$48M—Omada Health is a digital health company offering the Prevent program, a digitally-based lifestyle intervention that combines connected devices like wireless scales, proprietary health curricula, personal health coaching, and online peer support to help individuals at risk for obesity-related chronic diseases such as diabetes and heart disease reduce their risk. The company serves health plans and self-insured employers including Lowe’s, Costco, Iron Mountain, Humana, and Kaiser Permanente, with proven clinical outcomes including weight loss of 4.7% after one year in prediabetes participants and similar results to in-person programs for veterans. On September 16, 2015, Omada Health raised $48 million in a Series C funding round led by Norwest Venture Partners, with participation from strategic investors and customers Humana Inc. and Providence Health & Services, prior investors Andreessen Horowitz, US Venture Partners, and Rock Health, and new investors GE Ventures and dRx Capital. The funding aims to expand clinical research, enhance the Prevent program, scale operations to enroll hundreds of thousands of participants by end-2016 (from 20,000 enrolled to date and plans for 10,000 more by end-2015), and extend services to Medicaid and safety net populations. The company had grown its staff from 75 to 185 employees over the past year and operates on a pay-for-outcomes pricing model, paid only for participants achieving 5% or more body weight loss.
Apr-14Series BAndreessen Horowitz; Designer Fund; Kaiser Permanente Ventures; The Vertical Group; U.S. Venture Partners$23M—Omada Health, a pioneer in digital therapeutics, closed a $23 million Series B funding round on April 10, 2014, led by Andreessen Horowitz, with participation from Kaiser Permanente Ventures and existing investors including U.S. Venture Partners and The Vertical Group. Andreessen Horowitz general partner Balaji S. Srinivasan joined the board. The company focuses on digital health programs for preventing and managing chronic diseases like prediabetes through evidence-based interventions combining medicine, design, and technology. Omada's initial product, Prevent, targets the 80 million Americans with prediabetes, based on the Diabetes Prevention Program clinical trial promoted by the CDC under the Affordable Care Act. The platform delivers scalable, user-friendly digital therapy with clinical outcomes, outperforming traditional in-person programs. The team includes experts from Google, Amazon, IDEO, Harvard, and Stanford, emphasizing long-term behavior change to address preventable chronic conditions affecting three out of four Americans. Funds from the Series B were intended to scale operations, expand partnerships with organizations like Blue Cross Blue Shield Louisiana and Stanford Hospital, and grow digital therapy offerings beyond diabetes prevention. This round followed a $4.7 million Series A in March 2013.
Mar-13Series ADesigner Fund; Founder Collective; HealthTech Capital; Jeffrey Schox; Kapor Capital; New Enterprise Associates; Rock Health Capital; The Vertical Group; TriplePoint Capital; U.S. Venture Partners$5M——

Omada Health M&A Activity

Omada Health has acquired 1 company to date.

Last acquisition by Omada Health was on May 19th 2020. Omada Health acquired Physera for $30M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Omada Health

Physera
Description
Physera is a digital musculoskeletal care platform providing telehealth access to licensed physical therapists nationwide. Its app delivers video consultations, exercise animations, voice-guided therapy, and pain management tools to reduce injury-related downtime for employers and individuals.
HQ CountryUnited States
HQ City
San Francisco, CA
Deal Date19 May 2020
Valuation$30M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Omada Health acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Omada Health

When was Omada Health founded?Omada Health was founded in 2011.
Where is Omada Health headquartered?Omada Health is headquartered in United States.
How many employees does Omada Health have?As of today, Omada Health has over 849 employees.
Who is the CEO of Omada Health?Omada Health's CEO is Sean Duffy.
Is Omada Health publicly listed?Yes, Omada Health is a public company listed on Nasdaq.
What is the stock symbol of Omada Health?Omada Health trades under OMDA ticker.
When did Omada Health go public?Omada Health went public in 2025.
Who are competitors of Omada Health?Omada Health main competitors include Bayzed Health Group, Certara, Nutex Health, Yidu Tech, Enhabit, CareDx, InnovAge, Summerset Group Holdings, Ambea, Indegene.
What is the current market cap of Omada Health?Omada Health's current market cap is $907M.
What is the current revenue of Omada Health?Omada Health's last 12 months revenue is $280M.
What is the current revenue growth of Omada Health?Omada Health revenue growth (NTM/LTM) is 22%.
What is the current EV/Revenue multiple of Omada Health?Current revenue multiple of Omada Health is 2.6x.
Is Omada Health profitable?Yes, Omada Health is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Omada Health?Omada Health's last 12 months EBITDA is $8M.
What is Omada Health's EBITDA margin?Omada Health's last 12 months EBITDA margin is 3%.
What is the current EV/EBITDA multiple of Omada Health?Current EBITDA multiple of Omada Health is 88.4x.
What is the current FCF of Omada Health?Omada Health's last 12 months FCF is $14M.
What is Omada Health's FCF margin?Omada Health's last 12 months FCF margin is 5%.
What is the current EV/FCF multiple of Omada Health?Current FCF multiple of Omada Health is 49.7x.
How many companies Omada Health has acquired to date?As of May 2026, Omada Health has acquired 1 company.
What was the largest acquisition by Omada Health?$30M acquisition of Physera on 19th May 2020 was the largest M&A Omada Health has done to date.
What companies Omada Health acquired?Omada Health acquired Physera.
In how many companies Omada Health has invested to date?Omada Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Omada Health

Lists including Omada Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial